Latest Operational Updates News

Rincon Resources Limited has responded to an ASX query about recent unusual trading activity, confirming no undisclosed information but pointing to imminent drilling and assay results as possible drivers.

oOh!media has confirmed its half-year earnings for 2025 met market expectations, despite a significant non-cash impairment linked to the loss of a key Auckland Transport contract. The company maintains steady operational performance and updated guidance amid evolving market conditions.

PT Aneka Tambang Tbk (ANTAM) posted a 7% increase in sales to Rp23.19 trillion in the first half of 2024, driven by strong domestic gold sales, and reported a net profit of Rp1.51 trillion. The company also completed significant divestments, retaining control of SDA while divesting majority ownership in FHT.

Tamboran Resources Corporation advances its Beetaloo Basin gas project with record well flow rates and strategic partnerships, targeting initial production by mid-2026. The company is also progressing a farmout for Phase 2 acreage amid rising East Coast gas demand.

Bridge SaaS Limited reported a remarkable 524.6% revenue jump to $7.47 million for FY25, driven by its acquisition of Brightside Disability Support & Respite. Despite this growth, the company narrowed its loss to $1.13 million but remains unprofitable.

Australian Agricultural Projects Limited reported a strong 18% revenue increase and a 56% jump in net profit for FY2025, while preparing to directly manage a key orchard segment after lease changes.

Carbonxt Group Limited reported a 7.1% revenue increase and a significant EBITDA improvement in FY25, while commissioning delays at its Kentucky facility temper near-term optimism.

Mesoblast reports a strong FY2025 financial performance driven by the commercial launch of Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease in children. The company is advancing multiple clinical programs targeting inflammatory diseases, heart failure, and chronic low back pain.

Austral Gold Limited reported a net loss of US$1.3 million for the first half of 2025, while completing refurbishment of its Casposo plant to diversify production. Despite operational challenges and increased costs, the company leans on shareholder support and strategic investments to manage liquidity pressures.

Mesoblast Limited is set to release its full-year financial results and operational highlights for 2025, spotlighting its FDA-approved cell therapy and expanding global partnerships.

Kaili Resources has responded to an ASX price query following a dramatic rise in its share price, denying any undisclosed material information and confirming full compliance with ASX listing rules.

Data#3 Limited reported a robust FY25 with $3 billion in gross sales and an 11.4% rise in net profit before tax, underpinned by cloud, security, and AI demand. The company’s FY26 strategy focuses on customer experience and operational excellence amid evolving IT sector trends.